Resultados de la búsqueda 391-400 of 17671 for immune system

  1. Oncología (médica) - Ensayos clínicos

    This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and ...

  2. Oncología (médica) - Ensayos clínicos

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  3. Oncología (médica) - Ensayos clínicos

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  4. Oncología (médica) - Ensayos clínicos

    This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and ...

  5. Oncología (médica) - Ensayos clínicos

    This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system ... response to targeted therapy and immunotherapy for ...

  8. Oncología (médica) - Ensayos clínicos

    The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and ...

  10. Oncología (médica) - Ensayos clínicos

    The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...